Barclays raised its price target and reiterated an Overweight rating for Bruker.
2 reports, 2 independent
Updated Jun 25
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays raised its price target and reiterated an Overweight rating for Bruker.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Barclays
British bank
- QinetiQ carried out share purchases and arranged for a share buyback execution on the London Stock Exchange.
- Financial institutions provided ratings on multiple companies on July 8, 2026, including Goldman Sachs reiterating Tesla as neutral, Barclays initiating Toast as overweight, and Bank of America rating Nvidia as a buy.
-
Bruker
American company
Related events
- Barclays maintained Overweight rating and raised price target on August 29, 2025.
- Morgan Stanley reaffirmed an overweight rating on AbbVie, and Barclays raised its price objective on September 10, 2026.
- Barclays raised its price target on Latham Group on September 1, 2026.
- Barclays reiterated an overweight rating on the stock of Brighthouse Financial.
- Barclays boosted its price target on Bunge on August 16, 2026.